ARAVA Safety Questions, ARAVA Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about ARAVA. Our extensive database of ARAVA adverse events and ARAVA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about ARAVA
ARAVA Safety Reports
Total ARAVA reports: 492.ARAVA FDA safety alerts: 2003 .
Reported deaths: 61 Reported hospitalizations: 238.
Take ARAVA Side Effects Survey or Share Your ARAVA Story. ARAVA Usage.
Showing 1-75 of 492 Next >
Physician from BELGIUM reported ARAVA problem on Mar 05, 2007. Female patient, 38 years of age, weighting 222.7 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: haemodialysis, influenza, nephritis interstitial, pyelonephritis, renal failure acute. ARAVA dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, LEDERTREXATE, ELTHYRONE. Patient was hospitalized. Patient recovered.ARAVA problem was reported by a Pharmacist from JAPAN on Mar 08, 2007. Male patient, 73 years of age, weighting 160.9 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: bladder cancer recurrent. ARAVA dosage: unknown. During the same period patient was treated with MOBIC, PROMAC, OMEPRAL, PREDONINE, RHEUMATREX. Patient recovered.
Consumer or non-health professional from reported ARAVA problem on Mar 12, 2007. Female patient, 75 years of age, weighting 132.9 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: acute sinusitis, anorexia, arthralgia, condition aggravated, dry mouth, fatigue, malaise, red blood cell sedimentation rate increased, sudden hearing loss. ARAVA dosage: unknown. During the same period patient was treated with CALCICHEW, RELIFEX, SULFASALAZINE. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2007. Female patient was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder. ARAVA dosage: unknown. During the same period patient was treated with REMICADE. Patient died on 06/24/2005.
Pharmacist from UNITED KINGDOM reported ARAVA problem on Feb 26, 2007. Male patient was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: confusional state, creutzfeldt-jakob disease, diarrhoea, electroencephalogram abnormal, pyrexia. ARAVA dosage: unknown. Patient recovered.
ARAVA problem was reported by a Physician from JAPAN on Mar 14, 2007. Female patient, 58 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: impaired healing, nail disorder. ARAVA dosage: unknown. During the same period patient was treated with BOUIOUGITO, LASIX, PREDONINE, BREDININ, PRAVASTATIN, LOXONIN, OMEPRAZON, PREDOHAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from GERMANY reported ARAVA problem on Mar 15, 2007. Female patient, 56 years of age, weighting 202.8 lb, was diagnosed with rheumatoid arthritis, cystitis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: hepatitis acute. ARAVA dosage: unknown. During the same period patient was treated with ARCOXIA, ARTHROTEC, METHOTREXAT, CORTISONE ACETATE, ANTIBIOTICS. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Physician from UNITED STATES on Mar 12, 2007. Female patient, weighting 252.4 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: alopecia, diarrhoea, dysphagia, erythema multiforme, gastrointestinal haemorrhage, haematochezia, liver function test abnormal, mouth ulceration, neutropenia. ARAVA dosage: unknown. During the same period patient was treated with METHOTREXATE, SKELAXIN, PREDNISONE, FOLIC ACID, AMBIEN. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported ARAVA problem on Mar 13, 2007. Female patient, 78 years of age, weighting 121.3 lb, was diagnosed with rheumatoid arthritis, hypercholesterolaemia and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, emphysema, fatigue, pulmonary fibrosis, respiratory failure. ARAVA dosage: unknown. During the same period patient was treated with CORTANCYL, PRACTAZIN, PAROXETINE, TAHOR, OROCAL, ERCEFURYL. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from AUSTRALIA on Mar 14, 2007. Female patient, 71 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: squamous cell carcinoma. ARAVA dosage: unknown. Patient recovered.
Physician from UNITED STATES reported ARAVA problem on Mar 20, 2007. Female patient, weighting 212.0 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: colitis. ARAVA dosage: 20 MG DAILY PO. During the same period patient was treated with HUMIRA. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Physician from UNITED KINGDOM on Oct 24, 2006. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: pneumonitis, respiratory disorder. ARAVA dosage: unknown. Patient died.
Physician from MEXICO reported ARAVA problem on June 07, 2006. Female patient, weighting 5.73 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: cerebral ventricle dilatation. ARAVA dosage: unknown. During the same period patient was treated with DEFLAZACORT. Patient recovered.
ARAVA problem was reported by a Physician from SPAIN on Mar 13, 2007. Male patient, 25 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, chromaturia, rhabdomyolysis, transaminases increased. ARAVA dosage: unknown. During the same period patient was treated with DACORTIN, IBUPROFEN. Patient was hospitalized. Patient recovered.
Physician from ITALY reported ARAVA problem on Mar 15, 2007. Female patient, 63 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: alopecia, diarrhoea, eye inflammation, gastric ulcer, gastritis, hirsutism, stomach discomfort, weight decreased. ARAVA dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient recovered.
ARAVA problem was reported by a Physician from GERMANY on Mar 19, 2007. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: asthenia, leukopenia, thrombocytopenia. ARAVA dosage: unknown. During the same period patient was treated with QUANTALAN, QUENSYL, CORTICOSTEROIDS, PREDNISON. Patient was hospitalized. Patient died on 03/02/2007.
Consumer or non-health professional from AUSTRALIA reported ARAVA problem on Mar 16, 2007. Female patient, 56 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: cervix neoplasm. ARAVA dosage: unknown. During the same period patient was treated with MYFORTIC, THYROXIN. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from on Mar 21, 2007. Female patient, 74 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: non-hodgkin's lymphoma. ARAVA dosage: unknown. During the same period patient was treated with METHOTREXATE, REMICADE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported ARAVA problem on Mar 21, 2007. Female patient, 47 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: lentigo maligna stage i. ARAVA dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, KETOPROFEN. Patient recovered.
ARAVA problem was reported by a Physician from JAPAN on Mar 26, 2007. Male patient, 77 years of age, weighting 136.7 lb, was diagnosed with polymyalgia rheumatica and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, glucose urine present, jaundice, liver disorder. ARAVA dosage: unknown. During the same period patient was treated with PREDONINE, AZULFIDINE. Patient was hospitalized. Patient recovered.
Physician from ITALY reported ARAVA problem on Mar 23, 2007. Male patient, 30 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. ARAVA dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Health Professional from JAPAN on Mar 26, 2007. Female patient, 75 years of age, weighting 110.2 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: hypertension, sepsis, stomatitis, uterine cancer. ARAVA dosage: unknown. During the same period patient was treated with PREDONINE, NAIXAN, SELBEX, RHEUMATREX, RIMATIL, ISOTONIC CHLORIDE SOLUTION, ISOTONIC CHLORIDE SOLUTION, DECADRON. Patient died on 02/21/2005.
Pharmacist from NETHERLANDS reported ARAVA problem on Mar 23, 2007. Female patient, 65 years of age, weighting 136.7 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, hepatic function abnormal. ARAVA dosage: unknown. During the same period patient was treated with OMEPRAZOLE, PREDNISOLONE, ACTONEL, CALCIUM CARBONATE W. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Physician from NETHERLANDS on Mar 23, 2007. Female patient, 60 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatitis toxic. ARAVA dosage: unknown. During the same period patient was treated with RIVOTRIL, SELOKEEN, INFLIXIMAB. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from GREECE reported ARAVA problem on Mar 06, 2007. Female patient, 31 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abortion induced. ARAVA dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from AUSTRALIA on Mar 22, 2007. Female patient, 82 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: anorexia, diarrhoea, failure to thrive, nausea. ARAVA dosage: unknown. Patient died on 11/26/2006.
Physician from FRANCE reported ARAVA problem on Mar 26, 2007. Female patient, 82 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, dysglobulinaemia, inflammation, red blood cell sedimentation rate increased, serum ferritin increased, weight decreased. ARAVA dosage: unknown. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Physician from GERMANY on Mar 29, 2007. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: asthenia, diarrhoea, leukopenia, nasal congestion, ocular hyperaemia, pancytopenia, thrombocytopenia. ARAVA dosage: unknown. During the same period patient was treated with QUANTALAN, QUENSYL, METHOTREXAT, CORTICOSTEROIDS, PREDNISON. Patient was hospitalized. Patient died on 03/02/2007.
Consumer or non-health professional from BELGIUM reported ARAVA problem on Mar 29, 2007. Female patient, 75 years of age, weighting 147.7 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: chest pain, extrasystoles, hypertension. ARAVA dosage: unknown. During the same period patient was treated with EMCORETIC, PREDNISOLONE, ZESTORETIC. Patient recovered.
ARAVA problem was reported by a Physician from BELGIUM on Apr 02, 2007. Female patient, 72 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: rheumatoid nodule. ARAVA dosage: unknown. During the same period patient was treated with HUMIRA, CORTICOSTEROIDS. Patient recovered.
Consumer or non-health professional from reported ARAVA problem on Apr 02, 2007. Female patient, 71 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: osteitis, osteonecrosis. ARAVA dosage: unknown. During the same period patient was treated with CORTANCYL, ENBREL, VOLTAREN, NEXIUM. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from FRANCE on Apr 03, 2007. Female patient, 50 years of age, was diagnosed with asthma and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: cutaneous lupus erythematosus. ARAVA dosage: unknown. During the same period patient was treated with SINGULAIR, SERETIDE. Patient recovered.
Consumer or non-health professional from FRANCE reported ARAVA problem on Apr 03, 2007. Female patient, 72 years of age, was diagnosed with diabetes mellitus and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: skin necrosis. ARAVA dosage: unknown. During the same period patient was treated with LANTUS, FONZYLANE, STILNOX, OSTRAM, OMEPRAZOLE, LIPANTHYL, FLECAINIDE ACETATE. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from JAPAN on Apr 10, 2007. Female patient, 56 years of age, weighting 101.4 lb, was diagnosed with rheumatoid arthritis, sjogren's syndrome and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: purpura, rheumatoid arthritis, ulcer, vasculitis necrotising. ARAVA dosage: unknown. During the same period patient was treated with RHEUMATREX, FOLIAMIN, PREDNISOLONE, SALIGREN, TAKEPRON, SELBEX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported ARAVA problem on Apr 02, 2007. Female patient, 71 years of age, was diagnosed with rheumatoid arthritis, osteoporosis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: squamous cell carcinoma. ARAVA dosage: unknown. During the same period patient was treated with PREDNISOLONE, CALTRATE. Patient recovered.
ARAVA problem was reported by a Physician from DENMARK on Apr 10, 2007. Female patient, 56 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: cough, fibrosis, pneumonitis. ARAVA dosage: unknown. During the same period patient was treated with REMICADE, SULFASALAZINE, PLAQUENIL. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported ARAVA problem on Apr 06, 2007. Female patient, 36 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate decreased, fatigue, renal tubular acidosis. ARAVA dosage: unknown. During the same period patient was treated with DICLOFENAC. Patient recovered.
ARAVA problem was reported by a Pharmacist from NETHERLANDS on Apr 10, 2007. Female patient, 65 years of age, weighting 136.7 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, hepatic function abnormal. ARAVA dosage: unknown. During the same period patient was treated with OMEPRAZOLE, PREDNISOLONE, ACTONEL, CALCIUM CARBONATE W. Patient was hospitalized. Patient recovered.
Physician from NETHERLANDS reported ARAVA problem on Apr 10, 2007. Female patient, 60 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ascites, hepatic failure, hepatitis toxic, jaundice, vomiting. ARAVA dosage: unknown. During the same period patient was treated with RIVOTRIL, SELOKEEN, INFLIXIMAB. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Physician from GERMANY on Apr 13, 2007. Female patient, 62 years of age, weighting 143.3 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: cough, diarrhoea, hypothyroidism, leukopenia, neutropenia, pyrexia, tachyarrhythmia, viral infection. ARAVA dosage: unknown. During the same period patient was treated with PREDNI H, IBUPROFEN. Patient recovered.
Physician from FRANCE reported ARAVA problem on Apr 11, 2007. Male patient, 61 years of age, was diagnosed with rheumatoid arthritis, hypertension and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, colitis microscopic, diarrhoea. ARAVA dosage: unknown. During the same period patient was treated with CELEBREX, CORTANCYL, EURELIX. Patient recovered.
ARAVA problem was reported by a Physician from FRANCE on Apr 04, 2007. Female patient, 55 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: breast cancer recurrent. ARAVA dosage: unknown. Patient recovered.
Physician from NETHERLANDS reported ARAVA problem on Apr 10, 2007. Female patient, 52 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, nausea, renal failure, vomiting. ARAVA dosage: unknown. During the same period patient was treated with INDOCID, PREDNISOLONE, OMEPRAZOLE, CALCI, FOSAMAX, METOPROLOL RETARD, AMLODIPINE. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Physician from CZECH REPUBLIC on Apr 12, 2007. Male patient, 62 years of age, was diagnosed with rheumatoid arthritis, gastritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: anaemia megaloblastic, circulatory collapse. ARAVA dosage: unknown. During the same period patient was treated with METHOTREXATE, MEDROL, HELICID, SORTIS, POTASSIUM CHLORIDE, VIGANTOL, CALCIUM EFFERVESCENT. Patient was hospitalized. Patient recovered.
Physician from SWITZERLAND reported ARAVA problem on Apr 10, 2007. Male patient, 37 years of age, was diagnosed with arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: sarcoma. ARAVA dosage: unknown. During the same period patient was treated with DICLOFENAC. Patient recovered.
ARAVA problem was reported by a Physician from UNITED STATES on Apr 11, 2007. Female patient was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, eosinophilia, glomerulonephritis rapidly progressive, nephritis interstitial. ARAVA dosage: unknown. During the same period patient was treated with CYTOXAN, PREDNISONE. Patient recovered.
Physician from ITALY reported ARAVA problem on Mar 21, 2007. Male patient, 38 years of age, was diagnosed with psoriatic arthropathy and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: pregnancy of partner. ARAVA dosage: unknown. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from on Apr 16, 2007. Female patient, 47 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: alopecia, asthenia, hepatocellular damage, leukopenia, lymphopenia, neutropenia, weight decreased. ARAVA dosage: unknown. During the same period patient was treated with TANAKAN, XANAX, FLUVOXAMINE MALEATE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from reported ARAVA problem on Apr 19, 2007. Female patient, 58 years of age, weighting 138.9 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: hypopharyngeal cancer, metastatic neoplasm, squamous cell carcinoma. ARAVA dosage: unknown. During the same period patient was treated with CORTANCYL, HUMIRA, SPECIAFOLDINE, METHOTREXATE. Patient recovered.
ARAVA problem was reported by a Physician from NETHERLANDS on Apr 17, 2007. Female patient, 52 years of age, weighting 198.4 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, fatigue, nausea, renal failure, vomiting. ARAVA dosage: unknown. During the same period patient was treated with INDOCID, PREDNISOLONE, OMEPRAZOLE, CALCI, FOSAMAX, METOPROLOL RETARD, AMLODIPINE. Patient was hospitalized. Patient recovered.
Physician from SPAIN reported ARAVA problem on Apr 19, 2007. Male patient, child 2 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: accidental overdose. ARAVA dosage: DOSE: 20MG X 23 TABLETS. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Physician from INDIA on Apr 17, 2007. Male patient, 60 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: arthralgia, joint stiffness, psoriasis, skin lesion. ARAVA dosage: unknown. During the same period patient was treated with METHOTREXATE, PARAFFIN LIQUID, CLOBETASOL PROPIONATE, LEVOCETIRIZINE. Patient recovered.
Physician from DENMARK reported ARAVA problem on Apr 20, 2007. Female patient, 56 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: cough, fibrosis, pneumonitis. ARAVA dosage: unknown. During the same period patient was treated with REMICADE, SALAZOPYRIN, PLAQUENIL, METHOTREXATE. Patient recovered.
ARAVA problem was reported by a Physician from DENMARK on Apr 20, 2007. Female patient, 56 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: cough, fibrosis, pneumonitis. ARAVA dosage: unknown. During the same period patient was treated with REMICADE, SALAZOPYRIN, PLAQUENIL, METHOTREXATE. Patient recovered.
Physician from INDIA reported ARAVA problem on Apr 17, 2007. Male patient, 60 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: arthralgia, joint stiffness, psoriasis, skin lesion. ARAVA dosage: unknown. During the same period patient was treated with METHOTREXATE, PARAFFIN LIQUID, CLOBETASOL PROPIONATE, LEVOCETIRIZINE. Patient recovered.
ARAVA problem was reported by a Physician from NETHERLANDS on Apr 24, 2007. Female patient, 60 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ascites, hepatic failure, hepatitis toxic, jaundice, vomiting. ARAVA dosage: unknown. During the same period patient was treated with REMICADE, RIVOTRIL, SELOKEEN, LOSEC, ATENOLOL, DICLOFENAC. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported ARAVA problem on Apr 25, 2007. Male patient, 40 years of age, weighting 143.3 lb, was diagnosed with rheumatoid arthritis, prophylaxis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. ARAVA dosage: unknown. During the same period patient was treated with AZULFIDINE EN, MOVER, LOXONIN, MUCOSTA, ACINON, RHEUMATREX, PREDONINE, FOLIAMIN. Patient recovered.
ARAVA problem was reported by a Physician from GREECE on Apr 25, 2007. Female patient, 63 years of age, weighting 138.9 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, respiratory arrest. ARAVA dosage: unknown. During the same period patient was treated with ETANERCEPT. Patient was hospitalized. Patient died on 10/25/2006.
Physician from DENMARK reported ARAVA problem on Apr 24, 2007. Female patient, 56 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: cough, fibrosis, pneumonitis. ARAVA dosage: unknown. During the same period patient was treated with REMICADE, SALAZOPYRIN, PLAQUENIL, METHOTREXATE. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from POLAND on Apr 26, 2007. Female patient, 35 years of age, was diagnosed with rheumatoid arthritis, epilepsy and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, alopecia, flatulence, hypertension. ARAVA dosage: unknown. During the same period patient was treated with METYPRED, OLFEN, DEPAKENE, GABITRIL, ORGAMETRIL, AUGMENTIN, CLIMICIN, DALACIN T. Patient recovered.
Physician from FRANCE reported ARAVA problem on Apr 26, 2007. Female patient, 33 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abortion threatened, metrorrhagia. ARAVA dosage: unknown. During the same period patient was treated with CORTANCYL, FERROSTRANE, OMEPRAZOLE, DEDROGYL, PIPERACILLINE. Patient recovered.
ARAVA problem was reported by a Physician from CROATIA (local name: Hrvatska) on May 02, 2007. Female patient, 43 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatitis toxic, jaundice. ARAVA dosage: unknown. During the same period patient was treated with MEDROL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported ARAVA problem on Apr 26, 2007. Male patient, weighting 4.39 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: pulmonary valve stenosis, tricuspid valve incompetence, ventricular hypoplasia. ARAVA dosage: unknown. During the same period patient was treated with CORTANCYL, DOLIPRANE, OMEPRAZOLE, DEDROGYL, CACIT D. Patient recovered.
ARAVA problem was reported by a Physician from SWITZERLAND on Apr 30, 2007. Male patient, 37 years of age, was diagnosed with psoriasis, arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: sarcoma. ARAVA dosage: unknown. During the same period patient was treated with DICLOFENAC. Patient recovered.
Physician from FRANCE reported ARAVA problem on May 02, 2007. Female patient, 60 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: breast cancer recurrent. ARAVA dosage: unknown. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from on Apr 30, 2007. Female patient, child 2 years of age, weighting 26.35 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion. ARAVA dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported ARAVA problem on May 02, 2007. Female patient, 64 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, haemorrhoidal haemorrhage, transient ischaemic attack. ARAVA dosage: unknown. During the same period patient was treated with VIOXX. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from AUSTRALIA on May 02, 2007. Female patient, 58 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. ARAVA dosage: unknown. Patient recovered.
Physician from FRANCE reported ARAVA problem on May 03, 2007. Female patient, 70 years of age, was diagnosed with rheumatoid arthritis, breast cancer, osteoporosis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: breast cancer, neutropenia. ARAVA dosage: unknown. During the same period patient was treated with FEMARA, ACTONEL, OROCAL D. Patient recovered.
ARAVA problem was reported by a Physician from NETHERLANDS on May 03, 2007. Female patient, 60 years of age, weighting 167.6 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ascites, hepatic failure, hepatitis toxic, jaundice, vomiting. ARAVA dosage: unknown. During the same period patient was treated with REMICADE, RIVOTRIL, SELOKEEN, LOSEC, ATENOLOL, DICLOFENAC. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported ARAVA problem on May 04, 2007. Female patient, 82 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, dysglobulinaemia, inflammation, red blood cell sedimentation rate increased, serum ferritin increased, weight decreased. ARAVA dosage: unknown. During the same period patient was treated with CELECTOL, KARDEGIC, KALEORID, FEROGRAD, NEXIUM, SOLUPRED, STILNOX, TEMESTA. Patient was hospitalized. Patient recovered.
ARAVA problem was reported by a Consumer or non-health professional from FRANCE on Apr 26, 2007. Male patient, weighting 4.39 lb, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: pulmonary valve stenosis, tricuspid valve incompetence, ventricular hypoplasia. ARAVA dosage: unknown. During the same period patient was treated with CORTANCYL, DOLIPRANE, OMEPRAZOLE, DEDROGYL, CACIT D. Patient recovered.
Physician from INDIA reported ARAVA problem on May 01, 2007. Male patient, 60 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: arthralgia, joint stiffness, psoriasis, skin lesion. ARAVA dosage: unknown. During the same period patient was treated with METHOTREXATE, PARAFFIN LIQUID, CLOBETASOL PROPIONATE, LEVOCETIRIZINE, DIVAN. Patient recovered.
ARAVA problem was reported by a Physician from SPAIN on May 02, 2007. Female patient, 66 years of age, was diagnosed with rheumatoid arthritis, hypertension, dyslipidaemia, arthropathy, osteoarthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: anaemia, blood pressure systolic increased, body temperature decreased, bone marrow failure, cardiac failure, crepitations, ecchymosis, feeling abnormal, gamma-glutamyltransferase increased. ARAVA dosage: unknown. During the same period patient was treated with METHOTREXATE, METHYLPREDNISOLONE, ACOVIL, PREVENCOR, ACREL, DISNAL. Patient was hospitalized. Patient died on 02/28/2007.
Physician from CROATIA (local name: Hrvatska) reported ARAVA problem on May 07, 2007. Female patient, 43 years of age, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatitis toxic, jaundice, lymphadenopathy. ARAVA dosage: unknown. During the same period patient was treated with MEDROL. Patient was hospitalized. Patient recovered.
Showing 1-75 of 492 Next >
This
drug has an active FDA Safety Alert